Literature DB >> 7334080

Breakdown of the blood--cerebrospinal fluid barrier to immunoglobulin in mice injected intracerebrally with a neurotropic influenza A virus. Post-exposure treatment with monoclonal antibody promotes recovery.

P C Doherty, W Gerhard.   

Abstract

Mice may be protected from the invariably fatal consequences of intracerebral (i.c.) inoculation of A/WSN influnza virus by intravenous injection with 0.5 mg of virus-specific monoclonal anti-hemagglutinin antibody given 2 days after i.c. challenge. The integrity of the blood-cerebrospinal fluid (CSF) barrier in such mice has been examined by comparing specific immunoglobulin (Ig) titers in serum and CSF. It seems that the process of virus growth results directly in substantial breakdown of the blood-CSF barrier at some time between 63 and 96 h after i.c. exposure to virus. The exogenously administered, virus-specific monoclonal antibody is not obviously involved either in abrogating the integrity of this physiological barrier system or in promoting inflammation. In fact, higher Ig titers are found in CSF for an antibody that does not bind to the virus. This presumably reflects the fact tht virus-infected cells in the central nervous system are adsorbing specific Ig from the CSF.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7334080     DOI: 10.1016/0165-5728(81)90027-8

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  12 in total

1.  Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing).

Authors:  H W Virgin; R Bassel-Duby; B N Fields; K L Tyler
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

2.  Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis.

Authors:  J S Wolinsky; M N Waxham; A C Server
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

Review 3.  Antibody-mediated clearance of viruses from the mammalian central nervous system.

Authors:  B Dietzschold
Journal:  Trends Microbiol       Date:  1993-05       Impact factor: 17.079

Review 4.  Monoclonal antibodies against microorganisms.

Authors:  R A Polin
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

5.  Capacity of influenza virus-monoclonal antibody mixtures to stimulate memory and cytotoxic T lymphocyte populations.

Authors:  N Greenspan; J L Hurwitz; P C Doherty
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

6.  Rituximab-treated patients have a poor response to influenza vaccination.

Authors:  Robert A Eisenberg; Abbas F Jawad; Jean Boyer; Kelly Maurer; Kenyetta McDonald; Eline T Luning Prak; Kathleen E Sullivan
Journal:  J Clin Immunol       Date:  2012-10-14       Impact factor: 8.317

7.  Monoclonal antibody cure and prophylaxis of lethal Sindbis virus encephalitis in mice.

Authors:  J Stanley; S J Cooper; D E Griffin
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

8.  Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system.

Authors:  B Dietzschold; M Kao; Y M Zheng; Z Y Chen; G Maul; Z F Fu; C E Rupprecht; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

9.  Late dominance of the inflammatory process in murine influenza by gamma/delta + T cells.

Authors:  S R Carding; W Allan; S Kyes; A Hayday; K Bottomly; P C Doherty
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

10.  Phenotypic analysis of the inflammatory exudate in murine lymphocytic choriomeningitis.

Authors:  R Ceredig; J E Allan; Z Tabi; F Lynch; P C Doherty
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.